Antonini, Angelo

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., et al. (2009) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 1,445

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Olanow, C. W., Kieburtz, K., Odin, P., Espay, A. J., Standaert, D. G., Fernandez, H. H., Vanagunas, A., Othman, A. A., Widnell, K. L., Robieson, W. Z., et al. (2014) · The Lancet Neurology

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 716

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)

Vollenweider, F. X., Leenders, K. L., Scharfetter, C., Antonini, A., Maguire, P., Missimer, J., & Angst, J. (1997) · European Neuropsychopharmacology

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 353

The reliability of a deep learning model in clinical out-of-distribution MRI data: A multicohort study

Mårtensson, G., Ferreira, D., Granberg, T., Cavallin, L., Oppedal, K., Padovani, A., Rektorova, I., Bonanni, L., Pardini, M., Kramberger, M. G., et al. (2020) · Medical Image Analysis

Dementia and Cognitive Impairment ResearchDomain Adaptation and Few-Shot Learning

Cited by 176

Wearable sensor-based objective assessment of motor symptoms in Parkinson’s disease

Ossig, C., Antonini, A., Buhmann, C., Classen, J., Csoti, I., Falkenburger, B., Schwarz, M., Winkler, J., & Storch, A. (2016) · Journal of Neural Transmission

Context-Aware Activity Recognition SystemsParkinson's Disease Mechanisms and Treatments

Cited by 164

Impairment of Human Dopaminergic Neurons at Different Developmental Stages by Perfluoro-Octanoic Acid (PFOA) and Differential Human Brain Areas Accumulation of Perfluoroalkyl Chemicals

Di Nisio, A., Pannella, M., Vogiatzis, S., Sut, S., Dall'Acqua, S., Rocca, M. S., Antonini, A., Porzionato, A., De Caro, R., Bortolozzi, M., et al. (2022) · Environment International

Per- and polyfluoroalkyl substances researchFluorine in Organic Chemistry

Cited by 103

How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire

Morgante, L., Morgante, F., Moro, E., Epifanio, A., Girlanda, P., Ragonese, P., Antonini, A., Barone, P., Bonuccelli, U., Contarino, M. F., et al. (2007) · Parkinsonism & Related Disorders

Deep Brain Stimulation and Movement DisordersObsessive-Compulsive Spectrum Disorders

Cited by 94

Double-blind randomized trial of t-DCS versus sham in Parkinson patients with mild cognitive impairment receiving cognitive training

Biundo, R., Weis, L., Fiorenzato, E., Gentile, G., Giglio, M., Schifano, R., Campo, M. C., Marcon, V., Martinez-Martin, P., Bisiacchi, P., et al. (2015) · Brain Stimulation

Transcranial Magnetic Stimulation StudiesDeep Brain Stimulation and Movement Disorders

Cited by 79

Cost‐effectiveness of 123I‐FP‐CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy

Antonini, A., Berto, P., Lopatriello, S., Tamma, F., Annemans, L., & Chambers, M. (2008) · Movement Disorders

Health Systems, Economic Evaluations, Quality of LifeParkinson's Disease Mechanisms and Treatments

Cited by 58

Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers

Ceravolo, R., Antonini, A., Volterrani, D., Rossi, C., Goldwurm, S., Di Maria, E., Kiferle, L., Bonuccelli, U., & Murri, L. (2005) · Neurology

Parkinson's Disease Mechanisms and TreatmentsGenetics and Neurodevelopmental Disorders

Cited by 33

Quantification of plasma APOE4 with a novel automated Lumipulse immunoassay enables the identification of homozygous and heterozygous APOE ε4 carrier status

Musso, G., Cosma, C., Moz, S., Gabelli, C., Navaglia, F., Codemo, A., Zambon, C. F., Cagnin, A., Antonini, A., Corbetta, M., et al. (2026) · Clinica Chimica Acta

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 6